Of over 7,000 clinical trials registered in the Brussels EU, only about half have had their results published, according to a new analysis.
For many years now, failing to report unsuccessful study results has been common practice in the pharmaceutical industry. With billions of dollars at stake, drug companies have a vested interest in ensuring that the only studies we get to hear about are those they want us to hear about. But hiding the results of negative studies is only one of many ways in which the pharmaceutical industry and its stakeholders are deceiving us. Other ways include sponsoring the institutions and/or scientists that carry out its studies (thus ensuring they arrive at a ‘positive’ result); exaggerating the results of studies; and presenting incomplete data in studies.
To learn more about the ways in which drug companies deceive us about the results of their studies, read this article on our website.